Marjan Cruijsen
2PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Apr 07, 2021
Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation.Marjan Cruijsen, Jacobien R Hilberink, Walter J F M van der Velden
|Jun 13, 2020
Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study.M Cruijsen, W J F M van der Velden, A F J de Haan
Pageof 1
